Jean-Jacques Bienaimé

Jean-Jacques Bienaimé

Directeur/Bestuurslid bij IMMUNOME, INC.

Vermogen: 67 M $ op 30-04-2024

70 jaar
Health Technology
Consumer Services
Process Industries

Oorsprong van het eerstegraads netwerk van Jean-Jacques Bienaimé

EntiteitType entiteitIndustrie
271
Non-Profit Organization Miscellaneous Commercial Services 271
The Wharton School of the University of Pennsylvania
172
College/University Other Consumer Services 172
Public Company Biotechnology 84
62
Non-Profit Organization Pharmaceuticals: Major 62
Public Company Pharmaceuticals: Major 55
31
Private Company Investment Managers 31
Subsidiary Biotechnology 23
Extinct Pharmaceuticals: Major 20
Subsidiary Pharmaceuticals: Major 18
Public Company Biotechnology 15
12
Extinct Pharmaceuticals: Major 12
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
10
Extinct 10
SangStat Medical Corp.
8
Extinct Pharmaceuticals: Major 8
7
Extinct Chemicals: Major Diversified 7
7
Subsidiary Biotechnology 7

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Jean-Jacques Bienaimé via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Lamberto Andreotti

Faheem Hasnain

Helen Torley

Jeremy Levin

James Sapirstein

Mark Trudeau

Athena Countouriotis

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

PFIZER, INC. Pharmaceuticals: Major

Edmund Harrigan

Ian Read

Henry McKinnell

Michael Taylor

Constantine Dean Maglaris

Albert Bourla

General Counsel

Chief Executive Officer

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Executive Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

John Johnson

James Sapirstein

David Ricks

Willard Dere

Barbara Bodem

President

Chief Operating Officer

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Pyott

Paul Schimmel

Barry Greene

John Maraganore

Christoph Westphal

Director/Board Member

Founder

President

Chief Executive Officer

Founder

Harvard Medical School College/University

Richard Pops

Paul Friedman

Christoph Westphal

Elizabeth Nabel

Vasant Narasimhan

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Pharmaceuticals: Major

Barry Greene

Steven Holtzman

John Maraganore

James Topper

Lynn A. Taylor

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Faheem Hasnain

Steven Holtzman

John Maraganore

Paul Clancy

Corleen Roche

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

Director of Finance/CFO

College/University

Julian Baker

Jonathan Leff

Peter Hutt

Christoph Westphal

Katherine High

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Lamberto Andreotti

Henry McKinnell

Kenneth Frazier

David Ricks

Albert Bourla

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Paul Schimmel

Peter Hutt

Otis Brawley

Elizabeth Nabel

Vasant Narasimhan

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Ronald Martell

Ted Love

John Orwin

Daniel O'Day

Alexander Hardy

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Director/Board Member

Chief Executive Officer

Biotechnology

Ronald Martell

Clay Siegall

Isaac Barchas

Max Rosett

Director/Board Member

Chief Executive Officer

Founder

Chief Operating Officer

JOHNSON & JOHNSON Pharmaceuticals: Major

John Johnson

John Orwin

Elizabeth Anderson

Jennifer Taubert

Chairman

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Louis C. Drapeau

Richard Pops

James Topper

Isaac Barchas

Masters Business Admin

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Rutgers State University of New Jersey College/University

John Orwin

James Sapirstein

Elizabeth Anderson

Lizzie Ngo

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

Robert Bradway

Willard Dere

Chief Operating Officer

Corporate Officer/Principal

Chief Executive Officer

Chief Tech/Sci/R&D Officer

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

John Maraganore

May Kin Ho

Jacqualyn Fouse

Paul Clancy

Chairman

Director/Board Member

Chairman

Director/Board Member

Massachusetts Institute of Technology College/University

Paul Schimmel

Lamberto Andreotti

Henry McKinnell

Jeffrey Peterson

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Graduate Degree

Biotechnology

Ian Read

Jean-Christophe Tellier

David Ricks

Albert Bourla

Director/Board Member

President

President

President

VERASTEM, INC. Biotechnology

John Johnson

Richard H. Aldrich

Paul Friedman

Christoph Westphal

Director/Board Member

Founder

Director/Board Member

Chief Executive Officer

Princeton University College/University

Carl Feldbaum

Randy Meier

Paul Friedman

Ronald Cohen

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

NOVARTIS AG Pharmaceuticals: Major

David Pyott

Pablo Cagnoni

Susanne Antonie Schaffert

Vasant Narasimhan

Corporate Officer/Principal

Corporate Officer/Principal

Investor Relations Contact

Chief Executive Officer

Yale University College/University

Bruce Cozadd

Christopher G. Standlee

Peter Hutt

Max Rosett

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Trusts/Mutual Funds

Pablo Cagnoni

Kenneth Frazier

Muneer Satter

Albert Bourla

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Henry McKinnell

Mark Trudeau

David Ricks

Albert Bourla

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Harvard Law School College/University

Peter Hutt

Kenneth Frazier

Muneer Satter

Mark Enyedy

Graduate Degree

Graduate Degree

Graduate Degree

Graduate Degree

The University of Chicago College/University

Otis Brawley

John Maraganore

Vasant Narasimhan

Isaac Barchas

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

MOMENTA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Paul Schimmel

Peter Hutt

Christoph Westphal

Founder

Director/Board Member

Founder

ALKERMES PLC Pharmaceuticals: Major

Paul Schimmel

Richard Pops

Mark B. Skaletsky

Director/Board Member

Chief Executive Officer

Director/Board Member

Pharmaceuticals: Major

Ian Read

Henry McKinnell

John Johnson

Corporate Officer/Principal

President

Sales & Marketing

ACADIA PHARMACEUTICALS INC. Pharmaceuticals: Major

Julian Baker

Edmund Harrigan

Adora Ndu

Director/Board Member

Director/Board Member

Director/Board Member

Boston College College/University

Daniel Junius

Richard H. Aldrich

Philip Lo Scalzo

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Mark Enyedy

Constantine Dean Maglaris

Pamela M. Williamson

Undergraduate Degree

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Richard H. Aldrich

Christoph Westphal

James Topper

Founder

Founder

Director/Board Member

Medical Specialties

Mark Enyedy

Jeff Ajer

Pamela M. Williamson

Corporate Officer/Principal

Corporate Officer/Principal

Public Communications Contact

IMMUNOGEN, INC. Biotechnology

Daniel Junius

Mark B. Skaletsky

Mark Enyedy

Chief Executive Officer

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Paul Schimmel

Richard Pops

Mark B. Skaletsky

Founder

Chief Executive Officer

Director/Board Member

Miscellaneous Commercial Services

Ian Read

Jean-Christophe Tellier

David Ricks

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Paul Schimmel

Kenneth Frazier

Elizabeth Nabel

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Ian Read

Kenneth Frazier

Albert Bourla

Director/Board Member

Director/Board Member

Director/Board Member

SEAGEN INC. Pharmaceuticals: Major

Ted Love

Clay Siegall

John Orwin

Director/Board Member

Chief Executive Officer

Director/Board Member

Miscellaneous Commercial Services

Renee Connolly

Lynn A. Taylor

Pamela M. Williamson

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Pablo Cagnoni

Helen Torley

Ted Love

President

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Renee Connolly

James Sapirstein

Lynn A. Taylor

Public Communications Contact

Corporate Officer/Principal

Public Communications Contact

RUBIUS THERAPEUTICS Biotechnology

Pablo Cagnoni

Peter Hutt

Susanne Antonie Schaffert

Chief Executive Officer

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Pablo Cagnoni

Susanne Antonie Schaffert

Herve Hoppenot

Corporate Officer/Principal

Chief Executive Officer

President

Stanford Graduate School of Business College/University

Henry McKinnell

Bruce Cozadd

Jonathan Leff

Doctorate Degree

Masters Business Admin

Masters Business Admin

Statistieken

Internationaal

Verenigde Staten 45
Zwitserland 3
Frankrijk 2
Mexico 2
Ierland 2

Sectoraal

Health Technology 31
Consumer Services 12
Commercial Services 8
Finance 2
Miscellaneous 2

Operationeel

Director/Board Member 876
Corporate Officer/Principal 308
Independent Dir/Board Member 285
Chairman 205
Chief Executive Officer 168
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU